Pliant Therapeutics to Participate in the RBC Biotech Expert Insights Series: Pulmonary/Lung Disease Mini-Symposium
Details of the virtual presentation:
- Details of the virtual presentation:
The RBC Mini-Symposium will include company presentations and sessions with key opinion leaders from across several lung disease areas including sarcoidosis, scleroderma, and idiopathic pulmonary fibrosis (IPF). - Those interested in registering for the KOL sessions should contact their RBC sales representative.
- Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.
- For additional information about Pliant Therapeutics, visit www.pliantrx.com and follow us on Twitter , LinkedIn , Facebook and YouTube .